Vaxcyte, Inc. Common Stock

PCVXNASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
47.36 USD
↘ 1.40 (2.87%)AT CLOSE (11:59 AM EDT)
47.35
↘ 0.01 (0.02%)
POST MARKET (AS OF 05:33 PM EDT)
Post Market
AS OF 05:33 PM EDT
47.35
↘ 0.01 (0.02%)
🔴Market: CLOSED
Open?$48.70
High?$49.19
Low?$47.23
Prev. Close?$48.76
Volume?1.1M
Avg. Volume?1.6M
VWAP?$47.95
Rel. Volume?0.70x
Bid / Ask
Bid?$46.50 × 100
Ask?$55.00 × 100
Spread?$8.50
Midpoint?$50.75
Valuation & Ratios
Market Cap?6.8B
Shares Out?144.4M
Float?118.3M
Float %?90.3%
P/E Ratio?N/A
P/B Ratio?2.28
EPS?-$6.56
Dividend?0.00%
Ex-Dividend?N/A

Shares of Vaxcyte, Inc. Common Stock (PCVX) are trading at $47.36. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On the valuation side, PCVX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Themes
Biotech - Drug Development›Infectious Disease & Vaccines
Employees
507
Market Cap
6.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.vaxcyte.com
Listed
2020-06-12
Address
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS, CA 94070
Phone: 650-837-0111
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
34
Piotroski F-Score?0/9Weak
Altman Z-Score?10.10Safe
Confidence?49%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.66%High
Short Interest?13.8M
Days to Cover?7.8
Free Float118.3M
Avg Daily Volume1.8M
Settlement Date2026-05-15
Financial Health
Current Ratio?7.49Strong
Quick Ratio?7.49Strong
Cash Ratio?1.08Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
68
2.28CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-31.6%WEAK▾
ROA?
S&P
3
-28.3%WEAK▾
Cash Flow & Enterprise
FCF?$-814944000
Enterprise Value?$6.6B
Fundamentals ratios updated end of day
MarketsMoversWatchlist